These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32523508)
1. Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis-a Systematic Review and Meta-Analysis of Preclinical Research. Elliott E; Bailey O; Waldron FM; Hardingham GE; Chandran S; Gregory JM Front Neurosci; 2020; 14():511. PubMed ID: 32523508 [No Abstract] [Full Text] [Related]
2. Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Mehta AR; Walters R; Waldron FM; Pal S; Selvaraj BT; Macleod MR; Hardingham GE; Chandran S; Gregory JM Brain Commun; 2019 Aug; 1(1):fcz009. PubMed ID: 32133457 [TBL] [Abstract][Full Text] [Related]
3. Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis. Urbi B; Owusu MA; Hughes I; Katz M; Broadley S; Sabet A J Neurochem; 2019 Apr; 149(2):284-297. PubMed ID: 30520038 [TBL] [Abstract][Full Text] [Related]
4. Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial). Bella ED; Tramacere I; Antonini G; Borghero G; Capasso M; Caponnetto C; Chiò A; Corbo M; Eleopra R; Filosto M; Giannini F; Granieri E; Bella V; Lunetta C; Mandrioli J; Mazzini L; Messina S; Monsurrò MR; Mora G; Riva N; Rizzi R; Siciliano G; Silani V; Simone I; Sorarù G; Volanti P; Lauria G BMJ Open; 2017 Aug; 7(8):e015434. PubMed ID: 28801400 [TBL] [Abstract][Full Text] [Related]
5. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis. Cui R; Tuo M; Li P; Zhou C Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657 [TBL] [Abstract][Full Text] [Related]
6. Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis. Lanznaster D; Bejan-Angoulvant T; Gandía J; Blasco H; Corcia P Front Neurol; 2020; 11():697. PubMed ID: 32849187 [No Abstract] [Full Text] [Related]
7. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum. Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS; JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712 [TBL] [Abstract][Full Text] [Related]
9. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis. Agah E; Saleh F; Sanjari Moghaddam H; Saghazadeh A; Tafakhori A; Rezaei N Syst Rev; 2018 Dec; 7(1):237. PubMed ID: 30572951 [TBL] [Abstract][Full Text] [Related]
10. Cellular Chaperones As Therapeutic Targets in ALS to Restore Protein Homeostasis and Improve Cellular Function. Kalmar B; Greensmith L Front Mol Neurosci; 2017; 10():251. PubMed ID: 28943839 [TBL] [Abstract][Full Text] [Related]
12. Speech and language intervention for language impairment in patients in the FTD-ALS spectrum. Kiousi V; Arnaoutoglou M; Printza A Hell J Nucl Med; 2019; 22 Suppl():133-146. PubMed ID: 30877731 [TBL] [Abstract][Full Text] [Related]
14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
15. Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis. Kansal K; Mareddy M; Sloane KL; Minc AA; Rabins PV; McGready JB; Onyike CU Dement Geriatr Cogn Disord; 2016; 41(1-2):109-22. PubMed ID: 26854827 [TBL] [Abstract][Full Text] [Related]
16. Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia. Van Langenhove T; Piguet O; Burrell JR; Leyton C; Foxe D; Abela M; Bartley L; Kim WS; Jary E; Huang Y; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR J Alzheimers Dis; 2017; 58(1):163-170. PubMed ID: 28387671 [TBL] [Abstract][Full Text] [Related]
17. Als and Ftd: Insights into the disease mechanisms and therapeutic targets. Liscic RM Eur J Pharmacol; 2017 Dec; 817():2-6. PubMed ID: 29031901 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease. Talbot K; Ansorge O Hum Mol Genet; 2006 Oct; 15 Spec No 2():R182-7. PubMed ID: 16987882 [TBL] [Abstract][Full Text] [Related]
19. The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis. Chiò A; Brunetti M; Barberis M; Iazzolino B; Montuschi A; Ilardi A; Cammarosano S; Canosa A; Moglia C; Calvo A JAMA Neurol; 2016 Apr; 73(4):425-30. PubMed ID: 26903389 [TBL] [Abstract][Full Text] [Related]
20. Molecular basis of ALS and FTD: implications for translational studies. Liščić RM Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]